199 related articles for article (PubMed ID: 18517036)
1. Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction.
Walsh JK; Snyder E; Hall J; Randazzo AC; Griffin K; Groeger J; Eisenstein R; Feren SD; Dickey P; Schweitzer PK
Sleep; 2008 May; 31(5):659-72. PubMed ID: 18517036
[TBL] [Abstract][Full Text] [Related]
2. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
Lankford DA; Corser BC; Zheng YP; Li Z; Snavely DB; Lines CR; Deacon S
Sleep; 2008 Oct; 31(10):1359-70. PubMed ID: 18853933
[TBL] [Abstract][Full Text] [Related]
3. Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.
Walsh JK; Hall-Porter JM; Griffin KS; Dodson ER; Forst EH; Curry DT; Eisenstein RD; Schweitzer PK
Sleep; 2010 Sep; 33(9):1217-25. PubMed ID: 20857869
[TBL] [Abstract][Full Text] [Related]
4. Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement?
Walsh JK; Randazzo AC; Stone K; Eisenstein R; Feren SD; Kajy S; Dickey P; Roehrs T; Roth T; Schweitzer PK
Sleep; 2006 Apr; 29(4):433-43. PubMed ID: 16676776
[TBL] [Abstract][Full Text] [Related]
5. Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery.
Banks S; Van Dongen HP; Maislin G; Dinges DF
Sleep; 2010 Aug; 33(8):1013-26. PubMed ID: 20815182
[TBL] [Abstract][Full Text] [Related]
6. Cognitive workload and sleep restriction interact to influence sleep homeostatic responses.
Goel N; Abe T; Braun ME; Dinges DF
Sleep; 2014 Nov; 37(11):1745-56. PubMed ID: 25364070
[TBL] [Abstract][Full Text] [Related]
7. The impact of extended sleep on daytime alertness, vigilance, and mood.
Kamdar BB; Kaplan KA; Kezirian EJ; Dement WC
Sleep Med; 2004 Sep; 5(5):441-8. PubMed ID: 15341888
[TBL] [Abstract][Full Text] [Related]
8. Performance on the continuous performance test in children with ADHD is associated with sleep efficiency.
Gruber R; Grizenko N; Schwartz G; Bellingham J; Guzman R; Joober R
Sleep; 2007 Aug; 30(8):1003-9. PubMed ID: 17702270
[TBL] [Abstract][Full Text] [Related]
9. Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance.
Pejovic S; Basta M; Vgontzas AN; Kritikou I; Shaffer ML; Tsaoussoglou M; Stiffler D; Stefanakis Z; Bixler EO; Chrousos GP
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E890-6. PubMed ID: 23941878
[TBL] [Abstract][Full Text] [Related]
10. Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction.
Doty TJ; So CJ; Bergman EM; Trach SK; Ratcliffe RH; Yarnell AM; Capaldi VF; Moon JE; Balkin TJ; Quartana PJ
Sleep; 2017 Dec; 40(12):. PubMed ID: 29029309
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
12. Banking sleep: realization of benefits during subsequent sleep restriction and recovery.
Rupp TL; Wesensten NJ; Bliese PD; Balkin TJ
Sleep; 2009 Mar; 32(3):311-21. PubMed ID: 19294951
[TBL] [Abstract][Full Text] [Related]
13. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
[TBL] [Abstract][Full Text] [Related]
14. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
15. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
16. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night.
Dinges DF; Pack F; Williams K; Gillen KA; Powell JW; Ott GE; Aptowicz C; Pack AI
Sleep; 1997 Apr; 20(4):267-77. PubMed ID: 9231952
[TBL] [Abstract][Full Text] [Related]
17. Dissociating effects of global SWS disruption and healthy aging on waking performance and daytime sleepiness.
Groeger JA; Stanley N; Deacon S; Dijk DJ
Sleep; 2014 Jun; 37(6):1127-42. PubMed ID: 24882908
[TBL] [Abstract][Full Text] [Related]
18. Age-related reduction in daytime sleep propensity and nocturnal slow wave sleep.
Dijk DJ; Groeger JA; Stanley N; Deacon S
Sleep; 2010 Feb; 33(2):211-23. PubMed ID: 20175405
[TBL] [Abstract][Full Text] [Related]
19. Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia.
Dijk DJ; Stanley N; Lundahl J; Groeger JA; Legters A; Trap Huusom AK; Deacon S
J Psychopharmacol; 2012 Aug; 26(8):1096-107. PubMed ID: 22002961
[TBL] [Abstract][Full Text] [Related]
20. Modafinil improves alertness, vigilance, and executive function during simulated night shifts.
Walsh JK; Randazzo AC; Stone KL; Schweitzer PK
Sleep; 2004 May; 27(3):434-9. PubMed ID: 15164895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]